N-[1-[2-[5-[3-[[4-[3-[4-[3-(2,6-dimethylidenepiperidin-3-yl)-1-methylindazol-7-yl]-2-methylpiperazin-1-yl]propyl]cyclohexyl]methyl]-2-methylphenyl]-6-ethenyl-2-pyridinyl]-3,4-dihydro-1H-isoquinolin-8-yl]ethenyl]-1,3-benzothiazol-2-amine
C62H71N9S — CID 177020914
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[1-[2-[5-[3-[[4-[3-[4-[3-(2,6-dimethylidenepiperidin-3-yl)-1-methylindazol-7-yl]-2-methylpiperazin-1-yl]propyl]cyclohexyl]methyl]-2-methylphenyl]-6-ethenyl-2-pyridinyl]-3,4-dihydro-1H-isoquinolin-8-yl]ethenyl]-1,3-benzothiazol-2-amine
N-[1-[2-[5-[3-[[4-[3-[4-[3-(2,6-dimethylidenepiperidin-3-yl)-1-methylindazol-7-yl]-2-methylpiperazin-1-yl]propyl]cyclohexyl]methyl]-2-methylphenyl]-6-ethenyl-2-pyridinyl]-3,4-dihydro-1H-isoquinolin-8-yl]ethenyl]-1,3-benzothiazol-2-amine (PubChem CID 177020914) has the molecular formula C62H71N9S and a molecular weight of 974.38 g/mol. Its IUPAC name is N-[1-[2-[5-[3-[[4-[3-[4-[3-(2,6-dimethylidenepiperidin-3-yl)-1-methylindazol-7-yl]-2-methylpiperazin-1-yl]propyl]cyclohexyl]methyl]-2-methylphenyl]-6-ethenyl-2-pyridinyl]-3,4-dihydro-1H-isoquinolin-8-yl]ethenyl]-1,3-benzothiazol-2-amine.
Molecular Properties
| Compound Name | N-[1-[2-[5-[3-[[4-[3-[4-[3-(2,6-dimethylidenepiperidin-3-yl)-1-methylindazol-7-yl]-2-methylpiperazin-1-yl]propyl]cyclohexyl]methyl]-2-methylphenyl]-6-ethenyl-2-pyridinyl]-3,4-dihydro-1H-isoquinolin-8-yl]ethenyl]-1,3-benzothiazol-2-amine |
|---|---|
| PubChem CID | 177020914 |
| Molecular Formula | C62H71N9S |
| Molecular Weight | 974.38 g/mol |
| Exact Mass | 973.56 |
| IUPAC Name | N-[1-[2-[5-[3-[[4-[3-[4-[3-(2,6-dimethylidenepiperidin-3-yl)-1-methylindazol-7-yl]-2-methylpiperazin-1-yl]propyl]cyclohexyl]methyl]-2-methylphenyl]-6-ethenyl-2-pyridinyl]-3,4-dihydro-1H-isoquinolin-8-yl]ethenyl]-1,3-benzothiazol-2-amine |
| SMILES | C=Cc1nc(N2CCc3cccc(C(=C)Nc4nc5ccccc5s4)c3C2)ccc1-c1cccc(CC2CCC(CCCN3CCN(c4cccc5c(C6CCC(=C)NC6=C)nn(C)c45)CC3C)CC2)c1C |
| InChI | InChI=1S/C62H71N9S/c1-8-55-52(30-31-59(65-55)71-34-32-47-16-11-19-50(54(47)39-71)43(5)64-62-66-56-21-9-10-23-58(56)72-62)49-18-12-17-48(42(49)4)37-46-27-25-45(26-28-46)15-14-33-69-35-36-70(38-41(69)3)57-22-13-20-53-60(67-68(7)61(53)57)51-29-24-40(2)63-44(51)6/h8-13,16-23,30-31,41,45-46,51,63H,1-2,5-6,14-15,24-29,32-39H2,3-4,7H3,(H,64,66) |
| InChIKey | DACGWZLNWDISIZ-UHFFFAOYSA-N |
| XLogP | 13.68 |
| TPSA | 77.38 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 72 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 974.38 |
| LogP ≤ 5 | 13.68 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 177020914 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.